{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:06:29Z","timestamp":1788926789695,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03316-4","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:51:42Z","timestamp":1784184702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Oncogenic LncRNA-PVT1 in colorectal cancer: mechanisms of ceRNA-mediated progression and clinical implications"],"prefix":"10.1007","volume":"43","author":[{"given":"Fatemeh Sousanabadi","family":"Farahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mehrmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ghanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sadeghloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7906-2260","authenticated-orcid":false,"given":"Nayeralsadat","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"7","key":"3316_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069660","volume":"8","author":"NT Al-Greene","year":"2013","unstructured":"Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, et al. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. PLoS ONE. 2013;8(7):e69660. https:\/\/doi.org\/10.1371\/journal.pone.0069660.","journal-title":"PLoS ONE"},{"issue":"4","key":"3316_CR2","first-page":"304","volume":"28","author":"G Ayeldeen","year":"2024","unstructured":"Ayeldeen G, Zaki AK, Amer E, Abdellatif Z, Shaker OG, Said M, et al. NBAT1\/miR-21 axis in progression of colorectal cancer and impact of PVT-1 polymorphism on miR-145 expression level and its clinical significance. Contemp Oncol\/Wsp\u00f3\u0142cz Onkol. 2024;28(4):304\u201317.","journal-title":"Contemp Oncol\/Wsp\u00f3\u0142cz Onkol"},{"key":"3316_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-4690-5-4","volume":"5","author":"GB Beck-Engeser","year":"2008","unstructured":"Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, Wabl M. Pvt1-encoded microRNAs in oncogenesis. Retrovirology. 2008;5:4. https:\/\/doi.org\/10.1186\/1742-4690-5-4.","journal-title":"Retrovirology"},{"issue":"1","key":"3316_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-022-00409-w","volume":"10","author":"L Cab\u00fas","year":"2022","unstructured":"Cab\u00fas L, Lagarde J, Curado J, Lizano E, P\u00e9rez-Boza J. Current challenges and best practices for cell-free long RNA biomarker discovery. Biomark Res. 2022;10(1):62. https:\/\/doi.org\/10.1186\/s40364-022-00409-w.","journal-title":"Biomark Res"},{"issue":"3","key":"3316_CR5","first-page":"538","volume":"8","author":"J Chai","year":"2018","unstructured":"Chai J, Guo D, Ma W, Han D, Dong W, Guo H, et al. A feedback loop consisting of RUNX2\/LncRNA-PVT1\/miR-455 is involved in the progression of colorectal cancer. Am J Cancer Res. 2018;8(3):538\u201350.","journal-title":"Am J Cancer Res"},{"key":"3316_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.gene.2018.02.036","volume":"654","author":"Z Chang","year":"2018","unstructured":"Chang Z, Cui J, Song Y. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer. Gene. 2018;654:36\u201342. https:\/\/doi.org\/10.1016\/j.gene.2018.02.036.","journal-title":"Gene"},{"key":"3316_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208\u201319. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.006.","journal-title":"Cancer Lett"},{"issue":"1","key":"3316_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-020-01287-2","volume":"19","author":"S Chen","year":"2020","unstructured":"Chen S, Shen X. Long noncoding RNAs: functions and mechanisms in colon cancer. Mol Cancer. 2020;19(1):167.","journal-title":"Mol Cancer"},{"issue":"2","key":"3316_CR9","first-page":"661","volume":"12","author":"JV de Assis","year":"2022","unstructured":"de Assis JV, Coutinho LA, Oyeyemi IT, Oyeyemi OT. Diagnostic and therapeutic biomarkers in colorectal cancer: a review. Am J Cancer Res. 2022;12(2):661.","journal-title":"Am J Cancer Res"},{"key":"3316_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020717","author":"NTM Dinh","year":"2024","unstructured":"Dinh NTM, Nguyen TM, Park MK, Lee CH. Y-Box binding protein 1: unraveling the multifaceted role in cancer development and therapeutic potential. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25020717.","journal-title":"Int J Mol Sci"},{"key":"3316_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.651796","volume":"11","author":"T Du","year":"2021","unstructured":"Du T, Gao Q, Zhao Y, Gao J, Li J, Wang L, et al. Long non-coding RNA LINC02474 affects metastasis and apoptosis of colorectal cancer by inhibiting the expression of GZMB. Front Oncol. 2021;11:651796.","journal-title":"Front Oncol"},{"issue":"6","key":"3316_CR12","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.3892\/mmr.2018.8907","volume":"17","author":"H Fan","year":"2018","unstructured":"Fan H, Zhu JH, Yao XQ. Knockdown of long non-coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells. Mol Med Rep. 2018;17(6):8309\u201315. https:\/\/doi.org\/10.3892\/mmr.2018.8907.","journal-title":"Mol Med Rep"},{"issue":"4","key":"3316_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1724600818777242","volume":"33","author":"H Fan","year":"2018","unstructured":"Fan H, Zhu JH, Yao XQ. Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer. Int J Biol Markers. 2018;33(4):415\u201322. https:\/\/doi.org\/10.1177\/1724600818777242.","journal-title":"Int J Biol Markers"},{"key":"3316_CR14","doi-asserted-by":"publisher","first-page":"1329244","DOI":"10.3389\/fphar.2023.1329244","volume":"14","author":"N Fatemi","year":"2023","unstructured":"Fatemi N, Karimpour M, Bahrami H, Zali MR, Chaleshi V, Riccio A, et al. Current trends and future prospects of drug repositioning in gastrointestinal oncology. Front Pharmacol. 2023;14:1329244. https:\/\/doi.org\/10.3389\/fphar.2023.1329244.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3316_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10620-024-08774-2","volume":"70","author":"N Fatemi","year":"2025","unstructured":"Fatemi N, Mirbahari SN, Tierling S, Sanjabi F, Shahrivari S, AmeliMojarad M, et al. Emerging frontiers in colorectal cancer therapy: from targeted molecules to immunomodulatory breakthroughs and cell-based approaches. Dig Dis Sci. 2025;70(3):919\u201342. https:\/\/doi.org\/10.1007\/s10620-024-08774-2.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"3316_CR16","doi-asserted-by":"publisher","first-page":"14780","DOI":"10.1002\/jcb.28739","volume":"120","author":"E Gharib","year":"2019","unstructured":"Gharib E, Anaraki F, Baghdar K, Ghavidel P, Sadeghi H, Nasrabadi PN, et al. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis. J Cell Biochem. 2019;120(9):14780\u201390.","journal-title":"J Cell Biochem"},{"issue":"15","key":"3316_CR17","doi-asserted-by":"publisher","first-page":"13718","DOI":"10.18632\/oncotarget.3764","volume":"6","author":"SK Gopal","year":"2015","unstructured":"Gopal SK, Greening DW, Mathias RA, Ji H, Rai A, Chen M, et al. YBX1\/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment. Oncotarget. 2015;6(15):13718\u201330. https:\/\/doi.org\/10.18632\/oncotarget.3764.","journal-title":"Oncotarget"},{"issue":"10","key":"3316_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41419-022-05328-0","volume":"13","author":"H Guo","year":"2022","unstructured":"Guo H, Zhuang K, Ding N, Hua R, Tang H, Wu Y, et al. High-fat diet induced cyclophilin B enhances STAT3\/lncRNA-PVT1 feedforward loop and promotes growth and metastasis in colorectal cancer. Cell Death Dis. 2022;13(10):883. https:\/\/doi.org\/10.1038\/s41419-022-05328-0.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3316_CR19","doi-asserted-by":"publisher","first-page":"101042831769912","DOI":"10.1177\/1010428317699122","volume":"39","author":"K Guo","year":"2017","unstructured":"Guo K, Yao J, Yu Q, Li Z, Huang H, Cheng J, et al. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression. Tumor biology. 2017;39(4):1010428317699122.","journal-title":"Tumor biology"},{"key":"3316_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopha.2017.01.049","volume":"88","author":"T Huang","year":"2017","unstructured":"Huang T, Liu HW, Chen JQ, Wang SH, Hao LQ, Liu M, et al. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. Biomed Pharmacother. 2017;88:302\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.049.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3316_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/1541-7786.Mcr-07-0105","volume":"6","author":"K Huppi","year":"2008","unstructured":"Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, Martin SE, et al. The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res. 2008;6(2):212\u201321. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-07-0105.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"3316_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10552-021-01541-y","volume":"33","author":"A IdrissiJanati","year":"2022","unstructured":"IdrissiJanati A, Karp I, Latulippe J-F, Charlebois P, Emami E. Periodontal disease as a risk factor for sporadic colorectal cancer: results from Coldent study. Cancer Causes Control. 2022;33(3):463\u201372.","journal-title":"Cancer Causes Control"},{"key":"3316_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174352","author":"J Jin","year":"2023","unstructured":"Jin J, Yoshimura K, Sewastjanow-Silva M, Song S, Ajani JA. Challenges and prospects of patient-derived xenografts for cancer research. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15174352.","journal-title":"Cancers (Basel)"},{"key":"3316_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9010021","author":"L Lakemeyer","year":"2021","unstructured":"Lakemeyer L, Sander S, Wittau M, Henne-Bruns D, Kornmann M, Lemke J. Diagnostic and prognostic value of CEA and CA19-9 in colorectal cancer. Diseases. 2021. https:\/\/doi.org\/10.3390\/diseases9010021.","journal-title":"Diseases"},{"issue":"11","key":"3316_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-019-2077-0","volume":"10","author":"Z-X Liang","year":"2019","unstructured":"Liang Z-X, Liu H-S, Wang F-W, Xiong L, Zhou C, Hu T, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis. 2019;10(11):829.","journal-title":"Cell Death Dis"},{"issue":"11","key":"3316_CR26","first-page":"20565","volume":"8","author":"E Liu","year":"2015","unstructured":"Liu E, Liu Z, Zhou Y, Mi R, Wang D. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med. 2015;8(11):20565\u201372.","journal-title":"Int J Clin Exp Med"},{"key":"3316_CR27","doi-asserted-by":"crossref","unstructured":"Liu F, Dong Q, Huang J. Overexpression of LncRNA PVT1 predicts advanced clinicopathological features and serves as an unfavorable risk factor for survival of patients with gastrointestinal cancers. In: Karger AG Basel S, Switzerland: 2017. Vol. 43. p. 1077\u20131089.","DOI":"10.1159\/000481719"},{"key":"3316_CR28","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.2147\/cmar.S260537","volume":"12","author":"F Liu","year":"2020","unstructured":"Liu F, Wu R, Guan L, Tang X. Knockdown of PVT1 suppresses colorectal cancer progression by regulating MiR-106b-5p\/FJX1 Axis. Cancer Manag Res. 2020;12:8773\u201385. https:\/\/doi.org\/10.2147\/cmar.S260537.","journal-title":"Cancer Manag Res"},{"issue":"7","key":"3316_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1515\/cclm-2019-0052","volume":"57","author":"H Liu","year":"2019","unstructured":"Liu H, Ye D, Chen A, Tan D, Zhang W, Jiang W, et al. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers. Clin Chem Lab Med (CCLM). 2019;57(7):1073\u201383.","journal-title":"Clin Chem Lab Med (CCLM)"},{"issue":"1","key":"3316_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ame2.12299","volume":"6","author":"X Liu","year":"2023","unstructured":"Liu X, Xin Z, Wang K. Patient-derived xenograft model in colorectal cancer basic and translational research. Animal Model Exp Med. 2023;6(1):26\u201340. https:\/\/doi.org\/10.1002\/ame2.12299.","journal-title":"Animal Model Exp Med"},{"issue":"5","key":"3316_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3892\/mmr.2021.12434","volume":"24","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu Y, Zhu Z, Gong J, Dou W. Knockdown of lncRNA PVT1 inhibits the proliferation and accelerates the apoptosis of colorectal cancer cells via the miR-761\/MAPK1 axis. Mol Med Rep. 2021;24(5):794. https:\/\/doi.org\/10.3892\/mmr.2021.12434.","journal-title":"Mol Med Rep"},{"issue":"21","key":"3316_CR32","doi-asserted-by":"publisher","first-page":"13431","DOI":"10.3390\/ijms232113431","volume":"23","author":"M Lulli","year":"2022","unstructured":"Lulli M, Napoli C, Landini I, Mini E, Lapucci A. Role of non-coding RNAs in colorectal cancer: focus on long non-coding RNAs. Int J Mol Sci. 2022;23(21):13431.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3316_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3892\/ol.2022.13400","volume":"24","author":"Z Luo","year":"2022","unstructured":"Luo Z, Chen R, Hu S, Huang X, Huang Z. PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p\/CDK4 axis. Oncol Lett. 2022;24(2):280. https:\/\/doi.org\/10.3892\/ol.2022.13400.","journal-title":"Oncol Lett"},{"key":"3316_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103722","volume":"85","author":"J Ma","year":"2025","unstructured":"Ma J, Zhang Y, Sun Z, Guo H, Li X, Cai J, Zhang, L. LncRNA PVT1 promotes cuproptosis through transcriptional activation of FDX1 in colorectal cancer. Redox Biol. 2025;85:103722. https:\/\/doi.org\/10.1016\/j.redox.2025.103722.","journal-title":"Redox Biol"},{"key":"3316_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101113","volume":"23","author":"S Mehrara","year":"2021","unstructured":"Mehrara S, Mohammadpour H, Miri SR, Abdi S. Plasmacytoma variant translocation 1 and nicotinamide phosphoribosyl-transferase long noncoding RNAs promote colorectal cancer. Gene Rep. 2021;23:101113.","journal-title":"Gene Rep"},{"issue":"2","key":"3316_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from globocan. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"key":"3316_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051018","author":"C Muller","year":"2021","unstructured":"Muller C, Ihionkhan E, Stoffel EM, Kupfer SS. Disparities in early-onset colorectal cancer. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051018.","journal-title":"Cells"},{"key":"3316_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148900","volume":"932","author":"B Naseri","year":"2025","unstructured":"Naseri B, Farsad-Akhtar N, Mardi A, Baghbani E, Bornedeli S, Asadi M, et al. lncRNA PVT1 silencing inhibits gastric cancer cells\u2019 progression via enhancing chemosensitivity to paclitaxel. Gene. 2025;932:148900. https:\/\/doi.org\/10.1016\/j.gene.2024.148900.","journal-title":"Gene"},{"key":"3316_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/v12020174","author":"T Nogimori","year":"2020","unstructured":"Nogimori T, Ogami K, Oishi Y, Goda R, Hosoda N, Kitamura Y, et al. ABCE1 acts as a positive regulator of exogenous rna decay. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12020174.","journal-title":"Viruses"},{"key":"3316_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.","journal-title":"Front Endocrinol"},{"key":"3316_CR41","doi-asserted-by":"crossref","unstructured":"Pan X, Cheng R, Zhu X, Cai F, Zheng G, Li J, Gao C. Prognostic significance and diagnostic value of overexpressed lncRNA PVT1 in colorectal cancer. Clin Lab. 2019;(12)","DOI":"10.7754\/Clin.Lab.2019.190412"},{"key":"3316_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac035","volume":"10","author":"S Parmar","year":"2022","unstructured":"Parmar S, Easwaran H. Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterol Rep. 2022;10:goac035. https:\/\/doi.org\/10.1093\/gastro\/goac035.","journal-title":"Gastroenterol Rep"},{"issue":"1","key":"3316_CR43","first-page":"138","volume":"10","author":"G Ping","year":"2018","unstructured":"Ping G, Xiong W, Zhang L, Li Y, Zhang Y, Zhao Y. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. Am J Transl Res. 2018;10(1):138\u201349.","journal-title":"Am J Transl Res"},{"issue":"1","key":"3316_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-016-0524-4","volume":"15","author":"P Qi","year":"2016","unstructured":"Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016;15(1):39. https:\/\/doi.org\/10.1186\/s12943-016-0524-4.","journal-title":"Mol Cancer"},{"issue":"11","key":"3316_CR45","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.3390\/ijms22116147","volume":"22","author":"AF Radwan","year":"2021","unstructured":"Radwan AF, Shaker OG, El-Boghdady NA, Senousy MA. Association of MALAT1 and PVT1 variants, expression profiles and target miRNA-101 and miRNA-186 with colorectal cancer: correlation with epithelial-mesenchymal transition. Int J Mol Sci. 2021;22(11):6147.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3316_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41598-018-36985-x","volume":"9","author":"X Ren","year":"2019","unstructured":"Ren X, Cao D, Yang L, Li X, Zhang W, Xiao Y, et al. High expression of long non-coding RNA PVT1 predicts metastasis in han and uygur patients with gastric cancer in xinjiang. Chin Sci Rep. 2019;9(1):548.","journal-title":"Chin Sci Rep"},{"issue":"1","key":"3316_CR47","doi-asserted-by":"publisher","first-page":"13113","DOI":"10.1038\/s41598-023-40288-1","volume":"13","author":"M RezaSoltani","year":"2023","unstructured":"RezaSoltani M, Forouzesh F, Salehi Z, Zabihi M-R, Rejali L, Nazemalhosseini-Mojarad E. Identification of LncPVT1 and CircPVT1 as prognostic biomarkers in human colorectal polyps. Sci Rep. 2023;13(1):13113.","journal-title":"Sci Rep"},{"issue":"2","key":"3316_CR48","doi-asserted-by":"publisher","first-page":"G222","DOI":"10.1152\/ajpgi.00357.2018","volume":"317","author":"AQ Shang","year":"2019","unstructured":"Shang AQ, Wang WW, Yang YB, Gu CZ, Ji P, Chen C, et al. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p. Am J Physiol Gastrointest Liver Physiol. 2019;317(2):G222-g232. https:\/\/doi.org\/10.1152\/ajpgi.00357.2018.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"3316_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-020-01277-4","volume":"19","author":"K Shigeyasu","year":"2020","unstructured":"Shigeyasu K, Toden S, Ozawa T, Matsuyama T, Nagasaka T, Ishikawa T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer. 2020;19(1):155. https:\/\/doi.org\/10.1186\/s12943-020-01277-4.","journal-title":"Mol Cancer"},{"issue":"3","key":"3316_CR50","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3316_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1756-9966-29-144","volume":"29","author":"LA S\u00f8rby","year":"2010","unstructured":"S\u00f8rby LA, Andersen SN, Bukholm IR, Jacobsen MB. Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer. J Exp Clin Cancer Res. 2010;29(1):144. https:\/\/doi.org\/10.1186\/1756-9966-29-144.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"3316_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.2085","volume":"7","author":"Z Sun","year":"2024","unstructured":"Sun Z, Li X, Shi Y, Yao Y. LncRNA PVT1 facilitates the growth and metastasis of colorectal cancer by sponging with miR-3619-5p to regulate TRIM29 expression. Cancer Rep (Hoboken). 2024;7(6):e2085. https:\/\/doi.org\/10.1002\/cnr2.2085.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"6","key":"3316_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.2085","volume":"7","author":"Z Sun","year":"2024","unstructured":"Sun Z, Li X, Shi Y, Yao Y. LncRNA PVT1 facilitates the growth and metastasis of colorectal cancer by sponging with miR-3619-5p to regulate TRIM29 expression. Cancer Reports. 2024;7(6):e2085.","journal-title":"Cancer Reports"},{"issue":"1","key":"3316_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/bjc.2013.698","volume":"110","author":"Y Takahashi","year":"2014","unstructured":"Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer. 2014;110(1):164\u201371.","journal-title":"Br J Cancer"},{"issue":"2","key":"3316_CR55","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/ijms22020632","volume":"22","author":"K Taniue","year":"2021","unstructured":"Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2):632.","journal-title":"Int J Mol Sci"},{"key":"3316_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01584-7","author":"D Traversa","year":"2021","unstructured":"Traversa D, Simonetti G, Tolomeo D, Visci G, Macchia G, Ghetti M, et al. Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease. Br J Cancer. 2021. https:\/\/doi.org\/10.1038\/s41416-021-01584-7.","journal-title":"Br J Cancer"},{"issue":"7512","key":"3316_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nature13311","volume":"512","author":"Y-Y Tseng","year":"2014","unstructured":"Tseng Y-Y, Moriarity BS, Gong W, Akiyama R, Tiwari A, Kawakami H, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014;512(7512):82\u20136.","journal-title":"Nature"},{"issue":"2","key":"3316_CR58","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.974467","volume":"2","author":"YY Tseng","year":"2015","unstructured":"Tseng YY, Bagchi A. The PVT1-MYC duet in cancer. Mol Cell Oncol. 2015;2(2):e974467. https:\/\/doi.org\/10.4161\/23723556.2014.974467.","journal-title":"Mol Cell Oncol"},{"issue":"5","key":"3316_CR59","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.3892\/mmr.2018.8669","volume":"17","author":"C Wang","year":"2018","unstructured":"Wang C, Zhu X, Pu C, Song X. Upregulated plasmacytoma variant translocation 1 promotes cell proliferation, invasion and metastasis in colorectal cancer. Mol Med Rep. 2018;17(5):6598\u2013604. https:\/\/doi.org\/10.3892\/mmr.2018.8669.","journal-title":"Mol Med Rep"},{"key":"3316_CR60","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.omtn.2020.03.006","volume":"20","author":"H Wu","year":"2020","unstructured":"Wu H, Wei M, Jiang X, Tan J, Xu W, Fan X, et al. lncRNA PVT1 promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA\/VEGFR1\/AKT Axis. Mol Ther Nucleic Acids. 2020;20:438\u201350. https:\/\/doi.org\/10.1016\/j.omtn.2020.03.006.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3316_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.808889","volume":"12","author":"S Wu","year":"2022","unstructured":"Wu S, Yang X, Tang W, Familiari G, Relucenti M, Aschner M, et al. Chemotherapeutic risk lncRNA-PVT1 SNP sensitizes metastatic colorectal cancer to FOLFOX regimen. Front Oncol. 2022;12:808889.","journal-title":"Front Oncol"},{"issue":"1","key":"3316_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12935-023-02867-0","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu Y, Xu X. Long non-coding RNA signature in colorectal cancer: research progression and clinical application. Cancer Cell Int. 2023;23(1):28.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"3316_CR63","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.canlet.2013.02.060","volume":"335","author":"N Yamada","year":"2013","unstructured":"Yamada N, Noguchi S, Mori T, Naoe T, Maruo K, Akao Y. Tumor-suppressive microRNA-145 targets catenin \u03b4-1 to regulate Wnt\/\u03b2-catenin signaling in human colon cancer cells. Cancer Lett. 2013;335(2):332\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2013.02.060.","journal-title":"Cancer Lett"},{"key":"3316_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/nano10071424","author":"C Yang","year":"2020","unstructured":"Yang C, Merlin D. Lipid-based drug delivery nanoplatforms for colorectal cancer therapy. Nanomaterials. 2020. https:\/\/doi.org\/10.3390\/nano10071424.","journal-title":"Nanomaterials"},{"key":"3316_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217217","volume":"604","author":"H Yang","year":"2024","unstructured":"Yang H, Gong C, Wu Y, Xie X, Chen Y, Li Z, et al. LncRNA SNHG1 facilitates colorectal cancer cells metastasis by recruiting HNRNPD protein to stabilize SERPINA3 mRNA. Cancer Lett. 2024;604:217217.","journal-title":"Cancer Lett"},{"key":"3316_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.gene.2019.02.036","volume":"697","author":"L Yang","year":"2019","unstructured":"Yang L, Peng X, Jin H, Liu J. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma. Gene. 2019;697:94\u2013102. https:\/\/doi.org\/10.1016\/j.gene.2019.02.036.","journal-title":"Gene"},{"key":"3316_CR67","doi-asserted-by":"publisher","first-page":"1148930","DOI":"10.3389\/fonc.2023.1148930","volume":"13","author":"JNN Yau","year":"2023","unstructured":"Yau JNN, Adriani G. Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response. Front Oncol. 2023;13:1148930. https:\/\/doi.org\/10.3389\/fonc.2023.1148930.","journal-title":"Front Oncol"},{"issue":"4","key":"3316_CR68","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4149\/neo_2023_221208N1169","volume":"70","author":"H Yin","year":"2023","unstructured":"Yin H, Gu S, Li G, Yu H, Zhang X, Zuo Y. Long noncoding RNA PVT1 predicts poor prognosis and promotes the progression of colorectal cancer through the miR-24-3p\/NRP1 axis in zebrafish xenografts. Neoplasma. 2023;70(4):500\u201313. https:\/\/doi.org\/10.4149\/neo_2023_221208N1169.","journal-title":"Neoplasma"},{"issue":"1","key":"3316_CR69","first-page":"48","volume":"23","author":"X Yu","year":"2018","unstructured":"Yu X, Zhao J, He Y. Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p\/RUNX2 axis. J buon. 2018;23(1):48\u201354.","journal-title":"J buon"},{"key":"3316_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.954634","volume":"12","author":"M Zamani","year":"2022","unstructured":"Zamani M, Foroughmand A-M, Hajjari M-R, Bakhshinejad B, Johnson R, Galehdari H. CASC11 and PVT1 spliced transcripts play an oncogenic role in colorectal carcinogenesis. Front Oncol. 2022;12:954634.","journal-title":"Front Oncol"},{"key":"3316_CR71","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.2147\/cmar.S208983","volume":"11","author":"X Zeng","year":"2019","unstructured":"Zeng X, Liu Y, Zhu H, Chen D, Hu W. Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression. Cancer Manag Res. 2019;11:6981\u201393. https:\/\/doi.org\/10.2147\/cmar.S208983.","journal-title":"Cancer Manag Res"},{"key":"3316_CR72","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.2147\/ijn.S466490","volume":"19","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ali K, Wang J. Research advances of lipid nanoparticles in the treatment of colorectal cancer. Int J Nanomedicine. 2024;19:6693\u2013715. https:\/\/doi.org\/10.2147\/ijn.S466490.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"3316_CR73","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1089\/gtmb.2019.0078","volume":"23","author":"L Zhang","year":"2019","unstructured":"Zhang L, Mao J. Long-chain noncoding RNA PVT1 gene polymorphisms are associated with the risk and prognosis of colorectal cancer in the Han Chinese population. Genet Test Mol Biomarkers. 2019;23(10):728\u201336.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"8","key":"3316_CR74","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/apm.12555","volume":"124","author":"S Zhang","year":"2016","unstructured":"Zhang S, Zhang G, Liu J. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b. APMIS. 2016;124(8):649\u201358. https:\/\/doi.org\/10.1111\/apm.12555.","journal-title":"APMIS"},{"issue":"1","key":"3316_CR75","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3892\/ijmm.2018.3595","volume":"42","author":"J Zheng","year":"2018","unstructured":"Zheng J, Hu L, Cheng J, Xu J, Zhong Z, Yang Y, et al. lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR-26b to activate CTGF\/ANGPT2. Int J Mol Med. 2018;42(1):489\u201396. https:\/\/doi.org\/10.3892\/ijmm.2018.3595.","journal-title":"Int J Mol Med"},{"issue":"20","key":"3316_CR76","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1002\/cam4.3323","volume":"9","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Yu T, Zhao X, Gao X, Zhao Y, Liu G. Intratumor heterogeneity: A new perspective on colorectal cancer research. Cancer Med. 2020;9(20):7637\u201345. https:\/\/doi.org\/10.1002\/cam4.3323.","journal-title":"Cancer Med"},{"key":"3316_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154389","volume":"244","author":"X Zhu","year":"2023","unstructured":"Zhu X, Jin X, Li Z, Chen X, Zhao J. miR-152-3p facilitates cell adhesion and hepatic metastases in colorectal cancer via targeting AQP11. Pathology - Research and Practice. 2023;244:154389. https:\/\/doi.org\/10.1016\/j.prp.2023.154389.","journal-title":"Pathology - Research and Practice"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03316-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03316-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03316-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:21:15Z","timestamp":1788924075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03316-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["3316"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03316-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"222"}}